Professor Graham JacksonHon Clin Prof of Clin Haematology
Sunter NJ, Scott K, Hills R, Grimwade D, Taylor S, Worrillow LJ, Fordham SE, Forster VJ, Jackson G, Bomken S, Jones G, Allan JM. A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia .
Blood 2012, 119 (1), 196-205.
Cowell IG, Sondka Z, Smith K, Lee KC, Manville CM, Sidorczuk Lesthuruge M, Rance HA, Padget K, Jackson GH, Adachi N, Austin CA. A model for MLL translocations in therapy-related leukemia involving topoisomerase IIB mediated DNA strand breaks and gene proximity .
Proceedings of the National Academy of Sciences 2012. In Press.
Boyd KD, Ross FM, Chiecchio L, Dagrada GP, Konn ZJ, Tapper WJ, Walker BA, Wardell CP, Gregory WM, Szubert AJ, Bell SE, Child JA, Jackson GH, Davies FE, Morgan GJ, NCRI Haematology Oncology Studies. A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial .
Leukemia 2012, 26 (2), 349-355.
Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, Harrison CJ, Israels T, Bailey S. Burkitt's lymphoma .
Lancet 2012, 379 (9822), 1234-1244.
Morgan GJ, Davies FE, Gregory WM, Bell SE, Szubert AJ, Coy NN, Cook G, Feyler S, Johnson PRE, Rudin C, Drayson MT, Owen RG, Ross FM, Russell NH, Jackson GH, Child JA, NCRI Haematological Oncology. Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results .
Haematologica 2012, 97 (3), 442-450.
de Brito LR, Batey MA, Zhao Y, Squires MS, Maitland H, Leung HY, Hall AG, Jackson G, Newell DR, Irving JAE. Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma .
Leukemia Research 2011, 35 (9), 1233-1240.
Bigley V, Haniffa M, Doulatov S, Wang XN, Dickinson R, McGovern N, Spence L, Pagan S, Carey C, Dimmick I, Chua I, Wallis J, Lordan J, Morgan C, Kumararatne DS, Doffinger R, van der Burg M, van Dongen J, Cant A, Jackson G, Dick JE, Hambleton S, Collin M. Dendritic cell, monocyte, B and NK lymphoid deficiency: a novel but potentially fatal haematological disorder curable with haematopoietic stem cell transplantation .
In: Bone Marrow Transplantation: 37th European Group for Bone and Marrow Transplantation . 2011, Paris, France: Nature Publishing Group.
Morgan GJ, Child JA, Gregory WM, Szubert AJ, Cocks K, Bell SE, Navarro-Coy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross FM, Byrne J, Roddie H, Rudin C, Cook G, Jackson GH, Wu P, Davies FE, Natl Canc Res Inst. Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial .
Lancet Oncology 2011, 12 (8), 743-752.
Cooles FAH, Jackson GH, Menon G, Isaacs JD. Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis .50 (4), 810-812.
Morgan GJ, Davies FE, Gregory WM, Bell SE, Szubert AJ, Cook G, Drayson MT, Owen RG, Ross FM, Jackson GH, Child JA. MRC Myeloma IX, 6 Year Median Follow-up (FU) Highlights the Importance of Long-Term FU in Myeloma Clinical Trials and Differential Effects of Thalidomide in High- and Low-Risk Disease .
In: Blood: 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH) . 2011, San Diego, California, USA: American Society of Hematology.
Shamim Z, Ryder LP, Christensen IJ, Toubert A, Norden J, Collin M, Jackson G, Dickinson AM, Muller K. Prognostic Significance of Interleukin-7 Receptor-alpha Gene Polymorphisms in Allogeneic Stem-Cell Transplantation: A Confirmatory Study .
Transplantation 2011, 91 (7), 731-736.
Sturgess K, Slatter M, Bigley V, Haniffa M, Wang XN, Dickinson R, McGovern N, Jardine L, Pagan S, Chua I, Wallis J, Lordan J, Morgan C, Cant A, Gennery A, Edmondson R, Bacon C, Black F, Kirkham N, Jackson GH, Hambleton S, Collin MP. Reduced Intensity Hematopoietic Stem Cell Transplant Rescues Immune Function and Corrects Pulmonary Alveolar Proteinosis in DCML Deficiency/GATA 2 Mutation .
In: Blood: 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH) . 2011, San Diego, California, USA: American Society of Hematology.
Boyd KD, Ross FM, Drayson MT, Owen RG, Szubert AJ, Gregory WM, Wardell CP, Davies FE, Jackson GH, Child JA, Morgan GJ. The Interaction of Response and FISH-Based Risk Stratification to Better Define Clinical Outcome in Myeloma .
In: Blood: 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH) . 2011, San Diego, California, USA: American Society of Hematology.
Ruffin N, Ahmed SS, Osorio LM, Wang XN, Jackson GH, Collin MP, Ekre HP, Chiodi F, Dickinson AM. The Involvement of Epithelial Fas in a Human Model of Graft Versus Host Disease .
Transplantation 2011, 91 (9), 946-951.
Delgado J, Canals C, Attal M, Thomson K, Campos A, Martino R, Littlewood T, Jackson G, Milpied N, Boogaerts M, Hunter A, Janssen JJWM, Montoto S, Sureda A. The role of in vivo T-cell depletion on reduced-intensity conditioning allogeneic stem cell transplantation from HLA-identical siblings in patients with follicular lymphoma .
Leukemia 2011, 25 (3), 551-555.
Sunter NJ, Scott K, Hills R, Grimwade D, Taylor S, Worillow L, Jackson G, Bomken S, Jones G, Allan JM. A Functional Polymorphism In the CD95 Cell Death Receptor Associated with Prognosis In Acute Promyelocytic Leukemia .
In: 52nd Annual Meeting of the American Society of Hematology . 2010, Orlando, FL: Blood: American Society of Hematology.
Sunter NJ, Scott K, Hills R, Grimwade D, Taylor S, Worrillow L, Jackson G, Bomken S, Jones G, Allan JM. A Functional Polymorphism In the CD95 Cell Death Receptor Associated with Prognosis In Acute Promyelocytic Leukemia .
In: Blood: 52nd Annual Meeting of the American Society of Hematology . 2010, Orlando, Florida, USA: American Society of Hematology.
Pratt G, Fenton JAL, Allsup D, Fegan C, Morgan GJ, Jackson G, Sunter NJ, Hall AG, Irving JAE, Allan JM. A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma .
British Journal of Haematology 2010, 150 (3), 371-373.
Dickinson A, Pearce K, Jackson G, Collin M, Norden J, Holler E, Greinix H, Bickeboller H, Balvarca Y, Rocha V, Kolb H, Hromadnikova I, Sedlacek P, Gratwohl A. Clinical and genetic risk assessment for overall survival in haematopoietic stem cell transplantation .
In: 36th Annual Meeting of the European Group for Blood and Marrow Transplantat/9th Meeting of the EBMT Data Management Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Quality Management Meeting . 2010, Vienna, Austria: Bone Marrow Transplantation, Nature Publishing Group.
Morgan GJ, Davies FE, Gregory WM, Bell SE, Szubert AJ, Drayson MT, Ashcroft J, Owen RG, Cook G, Ross FM, Jackson GH, Russell NH, Child JA. Optimising Bone Disease In Myeloma, Zoledronic Acid Plus Thalidomide Combinations Improves Survival and Bone Endpoints Results of the MRC Myeloma IX Trial .
In: Blood: 52nd Annual Meeting of the American Society of Hematology . 2010, Orlando, Florida, USA: American Society of Hematology.
Morgan GJ, Davies FE, Gregory WM, Bell SE, Szubert AJ, Coy NN, Drayson MT, Owen RG, Cook G, Ross FM, Jackson GH, Child JA. Thalidomide Maintenance Significantly Improves Progression Free Survival (PFS) and Overall Survival (OS) of Myeloma Patients When Effective Relapse Treatments Are Used MRC Myeloma IX Results .
In: Blood: 52nd Annual Meeting of the American Society of Hematology . 2010, Orlando, Florida, USA: American Society of Hematology.
Morgan GJ, Davies FE, Cavenagh JD, Jackson GH. Position statement on the use of bortezomib in multiple myeloma .
International Journal of Laboratory Hematology 2008, 30 (1), 1-10.
Leung E, Shenton BK, Green K, Gould K, Jackson G, Talbot D. Changes in EBV gene load in renal transplant recipients .
Transplantation Proceedings 2003, 35 (2), 794-795.
Middleton PG, Dickinson AM, Jarvis M, Cavet J, Cullup H, Jackson GH. Clinical and genotypic risk factors for GvHD are modulated by prophylaxis: A multicentre cohort study of HLA matched sib-allo BMT .
In: Genes and Immunity: 17th European Histocompatability Conference . 2003, Baden, Germany: Nature Publishing Group.
Wang XN, Lange C, Schulz U, Sviland L, Eissner G, Oliver KM, Jackson GH, Holler E, Dickinson AM. Interleukin-10 modulation of alloreactivity and graft-versus-host reactions .
Transplantation 2002, 74 (6), 772-778.
Jarvis M, Schulz U, Dickinson AM, Sviland L, Jackson G, Konur A, Wang XN, Hromadnikova I, Kolb HJ, Eissner G, Holler E. The detection of apoptosis in a human in vitro skin explant assay for graft versus host reactions .
Journal of Clinical Pathology 2002, 55 (2), 127-132.
Leung E, Shenton BK, Jackson G, Gould FK, Yap C, Talbot D. Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood .
Journal of Immunological Methods 2002, 270 (2), 259-267.
Jackson G, Taylor P, Smith GM, Marcus R, Smith A, Chu P, Littlewood TJ, Duncombe A, Hutchinson M, Mehta AB, Johnson SA, Carey P, Mackie MJ, Ganly PS, Turner GE, Deane M, Schey S, Brookes J, Tollerfield SM, Wilson MP. A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation .
British Journal of Haematology 2001, 112 (1), 127-137.
Robertson JD, Testa NG, Russell NH, Jackson G, Parker AN, Milligan DW, Stainer C, Chakrabarti S, Dougal M, Chopra R. Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant .
Bone Marrow Transplantation 2001, 27 (12), 1283-1286.
Wells AW, Bown N, Reid MM, Hamilton PJ, Jackson GH, Taylor PR. Erythroleukaemia in the north of England: a population based study .
Journal of Clinical Pathology 2001, 54 (8), 608-612.
Sviland L, Hromadnikova I, Sedlacek P, Cermakova M, Stechova K, Holler E, Eissner G, Schulz U, Kolb HJ, Jackson G, Wang XN, Dickinson AM. Histological correlation between different centers using the skin explant model to predict graft-versus-host disease following bone marrow transplantation .
Human Immunology 2001, 62 (11), 1277-1281.
Cavet J, Dickinson AM, Norden J, Taylor PRA, Jackson GH, Middleton PG. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation .
Blood 2001, 98 (5), 1594-1600.
Wang XN, Dickinson AM, Sviland L, Vyth-Dreese FA, Jackson GH, Schumacher TNM, Haanen JBAG, Mutis T, Goulmy E. Minor histocompatibility antigen specific CTLs and in situ skin graft versus host reactions .
In: Blood: 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH) . 2001, Orlando, Florida, USA: American Society of Hematology.
Gerstenkorn C, Jackson G, Di Franco F, Thomusch O, Talbot D. Outcome of PTLD in renal and liver allograft recipients .
Transplantation Proceedings 2001, 33 (4), 2469-2472.
Adams I, Taylor PRA, Jackson GH, Angus B, Watson P, Mounter P, McKay P, Dickinson AM, Oliver K, Jack F. Development of a novel prognostic score for mantle cell lymphoma .
In: BLOOD . 2000.
Holler E, Schulz U, Jarvis M, Dickinson AM, Sviland L, Hromadnikova I, Jackson G, Konur A, Eissner G, Andreesen R. The detection of keratinocyte apoptosis in a human skin explant assays for prediction of graft-versus-host disease .
In: BLOOD . 2000.
Moorthy IT, Chippindale AJ, Jackson GH, McCluskey S. Grey-scale ultrasound appearances of chronic parotid enlargement in anorexia nervosa .
CLINICAL RADIOLOGY 1998, 53 (8), 623-623.
Chinnery PF, Shaw PJ, Ince PG, Jackson GH, Bishop RI. Fulminant encephalopathy due to the catastrophic primary antiphospholipid syndrome [15] .
Journal of Neurology Neurosurgery and Psychiatry 1997, 62 (3), 300-301.
JACKSON GH, CAREY PJ, CANT AJ, BOWN NP, REID MM. MYELODYSPLASTIC SYNDROMES IN CHILDREN .
BRITISH JOURNAL OF HAEMATOLOGY 1993, 84 (1), 185-186.
